Physician profile
Joseph Hellman
NPI 1912268343
$5,117.65
in general payments reported to CMS, 2019-2025
29 companies · $1,179 in 2025
The $1,179 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $608 · 2021: $178 · 2022: $430 · 2023: $1,203 · 2024: $671 · 2025: $1,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,052.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $777.93 | 2020-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Watchman Access System |
| Abiomed | $762.90 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $430.08 | 2019-2025 | Lifevest |
| Abbott Laboratories | $383.92 | 2019-2023 | Mitraclip |
| Siemens Medical Solutions USA, INC. | $318.45 | 2020 | |
| Glaxosmithkline, LLC. | $252.60 | 2025 | Nucala |
| Janssen Pharmaceuticals, INC | $177.32 | 2021-2024 | Xarelto |
| Pfizer INC. | $174.77 | 2019-2025 | |
| Novo Nordisk INC | $172.14 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $162.35 | 2023-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $154.63 | 2024-2025 | Optimizer |
| Bard Peripheral Vascular, INC. | $150.00 | 2019 | |
| Corindus INC. | $148.78 | 2019 | |
| Medtronic Vascular, INC. | $141.61 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $139.15 | 2024-2025 | Farxiga, Wainua |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $127.31 | 2025 | Asahi Peripheral Vascular Wires, Asahi Coronary Wires |
| Philips North America LLC | $101.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.32 | 2021-2025 | |
| Esperion Therapeutics, INC. | $85.47 | 2023-2024 | Nexletol |
| Alnylam Pharmaceuticals INC. | $75.48 | 2025 | Onpattro |
| Medicomp INC | $57.99 | 2025 | Telepatch Cardiac Monitor |
| Medtronic, INC. | $43.67 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.30 | 2025 | Livtencity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.62 | 2023 | Jardiance |
| W. L. Gore & Associates, INC. | $26.23 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Merck Sharp & Dohme LLC | $23.34 | 2024 | Verquvo |
| Shockwave Medical, INC | $22.21 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $21.72 | 2023 | Camzyos |
| Kiniksa Pharmaceuticals, Ltd. | $20.14 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.